Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK Industry Concerned Over 26% Sales Tax Prediction For 2023

Potential Impact Of Unprecedented Rebate Rate On Sustainability A Key Concern

Executive Summary

The UK government says it remains committed to the principle of co-creating a positive environment for the development of commercial medicines but there is concern in the life sciences sector over the revelation that companies could be made to pay as much as 26% of their sales in 2023 in rebates to the government.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS145637

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel